Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients-Reference-Cited by-同舟云学术

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

Published:2018-11-27 Issue:11 Volume:10 Page:856-866
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:
Short-container-title:WJH

Author:

Salmon Dominique,Trimoulet Pascale,Gilbert Camille,Solas Caroline,Lafourcade Eva,Chas Julie,Piroth Lionel,Lacombe Karine,Katlama Christine,Peytavin Gilles,Aumaitre Hugues,Alric Laurent,Boué François,Morlat Philippe,Poizot-Martin Isabelle,Billaud Eric,Rosenthal Eric,Naqvi Alissa,Miailhes Patrick,Bani-Sadr Firouzé,Esterle Laure,Carrieri Patrizia,Dabis François,Sogni Philippe,Wittkop Linda

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference40 articles.

1. Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

2. Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial

3. Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

4. Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study

5. Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of factors affecting response of direct-acting antivirals in chronic hepatitis C patients;Annals of African Medicine;2023

2. Efficacy and Safety of Adding Ribavirin to Direct-Acting Antivirals (DAAs) in Re-Treating Non-Genotype 1 Hepatitis C Infection- a Systematic Review and Meta-Analysis;2023

3. Impact of CD4+ T-cell count on sustained virologic response to direct-acting antivirals in hepatitis C virus monoinfected cancer patients: a prospective observational study;Diagnostic Microbiology and Infectious Disease;2022-07

4. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients;Current HIV Research;2021-09

5. Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study;World Journal of Gastroenterology;2021-05-14